Three Dimensional Conformal Radiotherapy Combined with Concurrent Chemotherapy for Stage Ⅲ Non-small Cell Lung Cancer
Background and objective The outcome of treatment for stage Ⅲ non-small cell lung cancer (NSCLC) by radiotherapy plus concurrent chemotherapy is poor. This study was aimed to investigate the feasibility of three-dimensional conformal radiotherapy (3D-CRT) plus concurrent cisplatin-based chemotherapy...
Main Authors: | Lili GAO, Wenke ZHU, Yide HU |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2009-09-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2009.09.013&path[]=1105 |
Similar Items
-
Stage III Esophageal Squamous Cell Carcinoma Patients With Three-Dimensional Conformal or Intensity-Modulated Radiotherapy: A Multicenter Retrospective Study
by: Qin Qin, et al.
Published: (2020-10-01) -
Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity
by: Matthias Felix Haefner, et al.
Published: (2017-08-01) -
Necessity of concurrent chemotherapy in N2‐3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity‐modulated radiotherapy
by: Hui Chang, et al.
Published: (2019-06-01) -
Dosimetric correlation of acute and late toxicities in high-risk prostate cancer patients treated with three-dimensional conformal radiotherapy followed by intensity modulated radiotherapy boost
by: Rakesh Kapoor, et al.
Published: (2016-01-01) -
Outcome of primary orbital lymphoma treated with induction chemotherapy followed by conformal radiotherapy
by: Supriya Mallick, et al.
Published: (2015-09-01)